REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics

Carhart-Harris, R.L., Friston, K.J.·2019·Pharmacological Reviews
DOI 10.1124/pr.118.017160

Cited by (999)

Items 201–300 of 999

  1. LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory
    S. Parker Singleton, Andrea I. Luppi, Robin L. Carhart-Harris, Josephine Cruzat, Leor Roseman, David J. Nutt, Gustavo Deco, Morten L. Kringelbach, Emmanuel Andreas Stamatakis, Amy F. Kuceyeski · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings
    Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard‐Devantoy, Kyle T. Greenway · 2023 · Frontiers in Human Neuroscience
  3. Giving Consent to the Ineffable
    Villiger, Daniel · 2024 · Neuroethics
  4. Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression
    David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Lester Carhart-Harris · 2024 · Journal of Psychopharmacology
  5. Transcranial focused ultrasound to the posterior cingulate cortex modulates default mode network and subjective experience: an fMRI pilot study
    Brian Lord, Joseph Lacoste Sanguinetti, Lisannette Ruiz, Vladimir Miskovic, Joel Segre, Shinzen Young, Maria E. Fini, John J. B. Allen · 2024 · Frontiers in Human Neuroscience
  6. Entity encounters and the therapeutic effect of the psychedelic mystical experience
    Anna Lutkajtis · 2021 · Journal of Evolutionary Psychology
  7. New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy
    Tehseen N. Noorani, Jonny Martell · 2021 · Frontiers in Psychiatry
  8. Are Psychedelic Medicines the Reset for Chronic Pain? Preliminary Findings and Research Needs
    F. Zia, M. Baumann, S. Belouin, R. Dworkin, Majid H. Ghauri, Peter S. Hendricks, J. Henningfield, R. Lanier, Stephen Ross, A. Berger · 2023 · Neuropharmacology
  9. Psychedelics alter metaphysical beliefs
    Christopher Timmermann, Hannes Kettner, Chris Letheby, Leor Roseman, Fernando E. Rosas, Robin Lester Carhart-Harris · 2021
  10. The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences
    Frymann, Tomas, Whitney, Sophie, Yaden, David B., Lipson, Joshua · 2022 · Frontiers in Psychology
  11. Neural mechanisms of psychedelic visual imagery
    Devon Stoliker, Katrin H. Preller, Leonardo Novelli, Alan Anticevic, Gary F. Egan, Franz X. Vollenweider, Adeel Razi · 2024 · Molecular Psychiatry
  12. Dissolving the self:Active inference, psychedelics, and ego-dissolution
    Deane, George · 2020 · Philosophy and the Mind Sciences
  13. Serotonergic neuromodulation of synaptic plasticity
    Higa, Guilherme Shigueto Vilar, Viana, Felipe José Costa, Francis-Oliveira, José, Cruvinel, Emily, Franchin, Thainá Soares, Marcourakis, Tania, Ulrich, Henning, De Pasquale, Roberto · 2024 · Neuropharmacology
  14. Out of the blue: understanding abrupt and wayward transitions in thought using probability and predictive processing
    Mills, Caitlin, Zamani, Andre, White, Rebecca, Christoff, Kalina · 2021 · Philosophical Transactions of the Royal Society B Biological Sciences
  15. Nonlinear EEG signatures of mind wandering during breath focus meditation
    Yiqing Lu, Julio Rodriguez‐Larios · 2022 · Current Research in Neurobiology
  16. History repeating: A roadmap to address common problems in psychedelic science
    Michiel van Elk, Eiko I. Fried · 2023
  17. A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex
    Andrea I. Luppi, Manesh Girn, Fernando E. Rosas, Christopher Timmermann, Leor Roseman, David Erritzøe, David Nutt, Emmanuel Andreas Stamatakis, R. Nathan Spreng, Lei Xing et al. · 2023 · Brain
  18. A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
    Blerida Banushi, Vince Polito · 2023 · Biology
  19. Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience
    S. Parker Singleton, Christopher Timmermann, Andrea I. Luppi, Emma Eckernäs, Leor Roseman, Robin Lester Carhart-Harris, Amy F. Kuceyeski · 2025 · Communications Biology
  20. Protocol for Outcome Evaluation of Ayahuasca-Assisted Addiction Treatment: The Case of Takiwasi Center
    Brian R. Rush, Olivia Marcus, Sara García, Anja Katharina Loizaga-Velder, Gabriel C. Loewinger, Ariane Spitalier, Fernando M. Mendive · 2021 · Frontiers in Pharmacology
  21. Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes
    Jacopo Sapienza, Marta Bosia, Marco Spangaro, Francesca Martini, Giulia Agostoni, Federica Cuoco, Federica Cocchi, Roberto Cavallaro · 2022 · Molecular Psychiatry
  22. Animal Behavior in Psychedelic Research
    Anna U. Odland, Jesper Langgaard Kristensen, Jesper Tobias Andreasen · 2022 · Pharmacological Reviews
  23. Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use
    Daniel Perkins, Simon Ruffell, Kimberley Day, Diego Pinzon Rubiano, Jerome J. Sarris · 2023 · Frontiers in Neuroscience
  24. Comparable roles for serotonin in rats and humans for computations underlying flexible decision-making
    Qiang Luo, Jonathan W. Kanen, Andrea Bari, Nikolina Skandali, Christelle Langley, Gitte M. Knudsen, Johan Alsiö, Benjamin U. Phillips, Barbara Jacquelyn Sahakian, Rudolf N. Cardinal et al. · 2023 · Neuropsychopharmacology
  25. The ego in psychedelic drug action – ego defenses, ego boundaries, and the therapeutic role of regression
    Tobias Buchborn, Hannes Kettner, Laura Kärtner, Marcus W. Meinhardt · 2023 · Frontiers in Neuroscience
  26. When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research
    Edward Jacobs, Ashleigh Murphy-Beiner, Ian Rouiller, David John Nutt, Meg J. Spriggs · 2023 · Neuroethics
  27. Therapeutic frameworks in integration sessions in substance‐assisted psychotherapy: A systematised review
    Sascha B. Thal, Paris Baker, Jonathon Marinis, Michelle Wieberneit, Jason M. Sharbanee, Raimundo Bruno, Petra Skeffington, Stephen Jason Bright · 2023 · Clinical Psychology & Psychotherapy
  28. Pathological claustrum activity drives aberrant cognitive network processing in human chronic pain
    Brent W. Stewart, Michael L. Keaser, Hwiyoung Lee, Sarah M. Margerison, Matthew Alexander Cormie, Massieh Moayedi, Martin A. Lindquist, Shuo Chen, Brian N. Mathur, David Anthony Seminowicz · 2024 · Current Biology
  29. Psilocybin for the Treatment of Obsessive-Compulsive Disorders
    Katja Ehrmann, John J. B. Allen, Francisco Moreno · 2021 · Current topics in behavioral neurosciences
  30. Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
    Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, Peter Oehen, Gregor Hasler · 2023 · Journal of Psychopharmacology
  31. Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study
    Kristjan Kaup, Madis Vasser, Kadi Tulver, Mari Munk, Juhan Pikamäe, Jaan Aru · 2023 · Frontiers in Psychiatry
  32. Apophenia, absorption and anxiety: Evidence for individual differences in positive and negative experiences of Hallucinogen Persisting Perceptual Disorder
    Alexander Irvine, David P. Luke · 2022 · Journal of Psychedelic Studies
  33. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect
    Hugo Bottemanne, Lucie Berkovitch, Christophe Gauld, Alexander Balcerac, Liane Schmidt, Stéphane Mouchabac, Philippe Fossati · 2023 · Neuroscience & Biobehavioral Reviews
  34. Psychedelics and sexual functioning: a mixed-methods study
    Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph M. Peill, Leor Roseman, David Nutt, David Erritzøe, Robin Lester Carhart-Harris, Bruna Giribaldi · 2024 · Scientific Reports
  35. The multimodal Ganzfeld-induced altered state of consciousness induces decreased thalamo-cortical coupling
    Timo Torsten Schmidt, Nisha Jagannathan, Michal Ljubljanac, Ann Xavier, Till Nierhaus · 2020 · Scientific Reports
  36. Psychedelics as potential catalysts of scientific creativity and insight
    Sam Gandy, Valérie Bonnelle, Edward Jacobs, David P. Luke · 2022 · Drug Science Policy and Law
  37. Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats
    Jonathan Reinwald, Christian Nikolaus Schmitz, Ivan Skorodumov, Martin Kuchař, Wolfgang Weber‐Fahr, Rainer Spanagel, Marcus W. Meinhardt · 2023 · Translational Psychiatry
  38. Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic Boundlessness
    Sepehr Mortaheb, Larry Douglas Fort, Natasha Leigh Mason, Pablo Mallaroni, Johannes Gerardus Ramaekers, Athena Demertzi A · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  39. Psychedelics and schizophrenia: Distinct alterations to Bayesian inference
    Hardik Rajpal, Pedro A. M. Mediano, Fernando E. Rosas, Christopher Timmermann, Stefan Peter Brugger, Suresh D Muthukumaraswamy, Anil K. Seth, Daniel Bor, Robin Lester Carhart-Harris, Henrik J. Jensen · 2022 · NeuroImage
  40. The Missing Piece? A Case for Microglia’s Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics
    Jared VanderZwaag, Torin Halvorson, Kira Dolhan, Eva Šimončičová, Benneth Ben‐Azu, Marie‐Ève Tremblay · 2022 · Neurochemical Research
  41. Psychedelic innovations and the crisis of psychopharmacology
    Nicolas Langlitz · 2022 · BioSocieties
  42. DMT alters cortical travelling waves
    Andrea Alamia, Christopher Timmermann, Rufin VanRullen, Robin Lester Carhart-Harris · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited?
    Daniel Villiger · 2024 · International Review of Psychiatry
  44. Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms
    Helen M Collins · 2024 · The International Journal of Neuropsychopharmacology
  45. Insights on psychedelics: A systematic review of therapeutic effects
    Joshua Kugel, Ruben Laukkonen, David B. Yaden, Murat Yücel, Paul Liknaitzky · 2025 · Neuroscience & Biobehavioral Reviews
  46. Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness
    Christopher Timmermann, James W. Sanders, David Reydellet, Tommaso Barba, Lisa Xiaolu Luan, Óscar Soto-Angona, Genís Oña, Giancarlo Allocca, Carl Hayden Smith, Zachary G. Daily et al. · 2025 · Neuroscience of Consciousness
  47. Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles
    Sophie A. Rogers, Elizabeth A. Heller, Gregory F. Corder · 2025 · Nature Neuroscience
  48. Psychopharmacology and Explanatory Pluralism
    Awais Aftab, Dan Joseph Stein · 2022 · JAMA Psychiatry
  49. Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review
    Sascha B. Thal, Michelle Wieberneit, Jason M. Sharbanee, Petra Skeffington, Paris Baker, Raimondo Bruno, Tobias Wenge, Stephen Jason Bright · 2022 · Journal of Psychopharmacology
  50. Historicizing psychedelics: counterculture, renaissance, and the neoliberal matrix
    Mateo Sánchez Petrement · 2023 · Frontiers in Sociology
  51. Modelling phenomenological differences in aetiologically distinct visual hallucinations using deep neural networks
    Keisuke Suzuki, Anil K. Seth, David J. Schwartzman · 2024 · Frontiers in Human Neuroscience
  52. Impact of Media-Induced Uncertainty on Mental Health: Narrative-Based Perspective.
    Kesner, Ladislav, Juríčková, Veronika, Grygarová, Dominika, Horáček, Jiří · 2025 · JMIR Mental Health
  53. A predictive processing framework of tool use
    Michiel van Elk · 2021 · Cortex
  54. Network dynamics scale with levels of awareness
    Peter Coppola, Lennart R. B. Spindler, Andrea I. Luppi, R. Adapa, Lorina Naçi, Judith E Allanson, Paola Finoia, Guy B. Williams, John Douglas Pickard, Adrian Mark Owen et al. · 2022 · NeuroImage
  55. Back from the rabbit hole. Theoretical considerations and practical guidelines on psychedelic integration for mental health specialists
    Jakub Greń, Filip Tylš, Michał Lasocik, Csaba Kiraly · 2023 · Frontiers in Psychology
  56. Psychedelia: The interplay of music and psychedelics
    Katarina Jerotic, Peter Vuust, Morten L. Kringelbach · 2023 · Annals of the New York Academy of Sciences
  57. Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review
    James J Gattuso, Carey Wilson, Anthony John Hannan, Thibault Renoir · 2023 · Journal of Neurochemistry
  58. Disembodiment and Affective Resonances in Esketamine Treatment of Depersonalized Depression Subtype: Two Case Studies
    Pietro Sarasso, Martina Billeci, Irene Ronga, F. Raffone, Vassilis Martiadis, Gilberto Di Petta · 2024 · Psychopathology
  59. A beautiful loop: An active inference theory of consciousness.
    Laukkonen, Ruben, Friston, Karl, Chandaria, Shamil · 2025 · Neuroscience & Biobehavioral Reviews
  60. The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience
    Hanna M. Tolle, Juan Carlos Farah, Pablo Mallaroni, Natasha Leigh Mason, Johannes Gerardus Ramaekers, Enrico Amico · 2023 · Network Neuroscience
  61. An international mega-analysis of psychedelic drug effects on brain circuit function
    Manesh Girn, Manoj K. Doss, Leor Roseman, Katrin H. Preller, Fernanda Palhano-Fontes, Lorenzo Pasquini, Frederick Streeter Barrett, Pablo Mallaroni, Natasha Leigh Mason, Christopher Timmermann et al. · 2026 · Nature Medicine
  62. MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
    Robin J. Murphy, Rachael L. Sumner, William Evans, David Benjamin Menkes, Ingo Lambrecht, Rhys Ponton, Frederick Sundram, Nicholas R. Hoeh, Sanya Ram, Lisa Reynolds et al. · 2021 · Trials
  63. Philosophy and classic psychedelics: A review of some emerging themes
    Chris Letheby, Jaipreet Mattu · 2022 · Journal of Psychedelic Studies
  64. Microdosing as a Response to the Meaning Crisis: A Qualitative Analysis
    Rotem Petranker, Juensung J. Kim, Thomas Anderson · 2022 · Journal of Humanistic Psychology
  65. Set and setting in microdosing: an oft-overlooked principle
    Ido Hartogsohn, Rotem Petranker · 2022 · Psychopharmacology
  66. Bedside to bench: the outlook for psychedelic research
    Victor Pablo Acero, Emily S. Cribas, Kevin D. Browne, Olivia M. Rivellini, Justin C. Burrell, John C. O’Donnell, Suradip Das, D. Kacy Cullen · 2023 · Frontiers in Pharmacology
  67. Inter-individual variability in neural response to low doses of LSD
    Nadia R. P. W. Hutten, Conny W.E.M. Quaedflieg, Natasha Leigh Mason, Eef Lien Theunissen, Matthias E. Liechti, Urs Duthaler, Kim P. C. Kuypers, Valérie Bonnelle, Amanda Feilding, Johannes Gerardus Ramaekers · 2024 · Translational Psychiatry
  68. The science of psychedelic medicine
    Joshua S. Siegel, Conor M. Liston, Ginger E. Nicol, Robin Lester Carhart-Harris, Michael P. Bogenschutz · 2026 · Nature Medicine
  69. The altered state of consciousness induced by Δ9-THC
    Conor H. Murray, Bhargav Srinivasa Desikan · 2022 · Consciousness and Cognition
  70. Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
    Mathias Ebbesen Jensen, Dea Siggaard Stenbæk, Tobias Søgaard Juul, Patrick M. Fisher, Claus Thorn Ekstrøm, Gitte M. Knudsen, Anders Fink‐Jensen · 2022 · BMJ Open
  71. The complexity of the stream of consciousness
    Peter Coppola, Judith E Allanson, Lorina Naçi, R. Adapa, Paola Finoia, Guy B. Williams, John Douglas Pickard, Adrian Mark Owen, David Krishna Menon, Emmanuel Andreas Stamatakis · 2022 · Communications Biology
  72. New Pharmacologic Approaches to the Treatment of Bipolar Depression
    Kamyar Keramatian, Trisha Chakrabarty, Anaïs DuBow, Gayatri Saraf, Lakshmi N. Yatham · 2023 · Drugs
  73. The psychedelic effects of cannabis: A review of the literature
    David Wolinsky, Frederick Streeter Barrett, Ryan G. Vandrey · 2023 · Journal of Psychopharmacology
  74. Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility
    Merima Šabanović, Alberto Lazari, Marta Blanco-Pozo, Cristiana Tisca, Mohamed Tachrount, Aurea B. Martins-Bach, Jason P. Lerch, Mark E. Walton, David M. Bannerman · 2024 · Molecular Psychiatry
  75. Instability and Uncertainty Are Critical for Psychotherapy: How the Therapeutic Alliance Opens Us Up
    Patrick M. Connolly · 2022 · Frontiers in Psychology
  76. The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies
    Zhen Xuen Brandon Low, Wei Shen Ng, Eugene Sheng Yao Lim, Bey Hing Goh, Yatinesh Kumari · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  77. Oscillatory Traveling Waves Provide Evidence for Predictive Coding Abnormalities in Schizophrenia
    Andrea Alamia, Darío Gordillo, Eka D. Chkonia, Maya Roinishvili, Céline Cappe, Michael H. Herzog · 2024 · Biological Psychiatry
  78. The Digital Phenotyping Project: A Psychoanalytical and Network Theory Perspective
    Rémy Potier · 2020 · Frontiers in Psychology
  79. Depression as a Disorder of Consciousness
    Cecily M. K. Whiteley · 2021 · The British Journal for the Philosophy of Science
  80. Reduced death anxiety and obsessive beliefs as mediators of the therapeutic effects of psychedelics on obsessive compulsive disorder symptomology
    Sam G. Moreton, Amber Burden-Hill, Rachel E. Menzies · 2022 · Clinical Psychologist
  81. Psychedelic Psychoanalysis: Transformations of the Self
    Megan Rundel · 2022 · Psychoanalytic Dialogues
  82. Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective
    Daniel Meling, Milan Scheidegger · 2023 · Frontiers in Psychology
  83. This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience
    Pascal Michael, David P. Luke, Oliver C. Robinson · 2023 · Frontiers in Psychology
  84. Psychedelics and neonihilism: connectedness in a meaningless world
    Patric Plesa, Rotem Petranker · 2023 · Frontiers in Psychology
  85. Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being
    Valérie Bonnelle, Amanda Feilding, Fernando E. Rosas, David John Nutt, Robin Lester Carhart-Harris, Christopher Timmermann · 2024 · Journal of Psychopharmacology
  86. Classification schemes of altered states of consciousness
    Larry Douglas Fort, Cyril Costines, Marc Wittmann, Athena Demertzi A, Timo Torsten Schmidt · 2025 · Neuroscience & Biobehavioral Reviews
  87. Meditation and complexity: a review and synthesis of evidence
    Daniel Andrew Atad, Pedro A. M. Mediano, Fernando E. Rosas, Aviva Berkovich‐Ohana · 2025 · Neuroscience of Consciousness
  88. Individual differences in sensory and expectation driven interoceptive processes: a novel paradigm with implications for alexithymia, disordered eating and obesity
    Hayley Anne Young, Chantelle M. Gaylor, Danielle de‐Kerckhove, David Benton · 2021 · Scientific Reports
  89. Psychedelic Epistemology: William James and the “Noetic Quality” of Mystical Experience
    Ron Cole‐Turner · 2021 · Religions
  90. Will psilocybin lose its magic in the clinical setting?
    Caroline Hayes, Mourad Wahba, Stuart Watson · 2022 · Therapeutic Advances in Psychopharmacology
  91. Reduced Precision Underwrites Ego Dissolution and Therapeutic Outcomes Under Psychedelics
    Devon Stoliker, Gary F. Egan, Adeel Razi · 2022 · Frontiers in Neuroscience
  92. Self-Actualization and the Integration of Psychedelic Experience: The Mediating Role of Perceived Benefits to Narrative Self-Functioning
    Nicole M. Amada, Jacob Shane · 2022 · Journal of Humanistic Psychology
  93. An encounter with the self: A thematic and content analysis of the DMT experience from a naturalistic field study
    Pascal Michael, David P. Luke, Oliver C. Robinson · 2023 · Frontiers in Psychology
  94. Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing
    Daniel Perkins, Emérita Sátiro Opaleye, José Carlos Bouso, Luís Fernando Tófoli, Jerome J. Sarris, Violeta Schubert, Simon Ruffell, Hana Šimonová · 2023 · Psychoactives
  95. Reduction of alcohol use and increase in psychological flexibility after a naturalistic psychedelic experience: a retrospective survey
    Ewen Kervadec, Baptiste Fauvel, Lana Strika-Bruneau, Ammar Amirouche, Vincent Verroust, Pascale Piolino, Bruno Roméo, Amine Benyamina · 2023 · Alcohol and Alcoholism
  96. Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial
    Robin J. Murphy, Kate E.M. Godfrey, Alexander D. Shaw, Suresh D Muthukumaraswamy, Rachael L. Sumner · 2024 · BMC Neuroscience
  97. Psychedelics and the ‘inner healer’: Myth or mechanism?
    Joseph M. Peill, M. Marguilho, David Erritzøe, Tommaso Barba, Kyle T. Greenway, Fernando E. Rosas, Christopher Timmermann, Robin Lester Carhart-Harris · 2024 · Journal of Psychopharmacology
  98. The inner screen model of consciousness: applying the free energy principle directly to the study of conscious experience
    Maxwell J. D. Ramstead, Mahault Albarracin, Alex B. Kiefer, Brennan Klein, Chris Fields, Karl John Friston, Adam Safron · 2023
  99. Do psychedelics facilitate emergence of unconscious psychological processes
    Lindegaard, Tomas · 2023 · Psychodynamic Psychiatry
  100. Psychedelic therapy – refining the claim of a paradigm shift
    Helena D. Aicher, M. Wolff, Uwe Herwig · 2024 · International Review of Psychiatry